INTANGIBLE ASSETS PATENTS (Details) (USD $)	Mar. 31, 2013	Dec. 31, 2011	Sep. 29, 2009	Sep. 17, 2009
Merger Agreement common stock issued				4,500,000
Pharma Tech to sell a minimum of the product each year				$ 500,000
BioPharma transaction intangible asset recorded in the amount				4,187,815
Common share issued on the date of acquisition par value per share				$ 0.93
Agreement resulting in an impairment		3,208,372
Accumulated amortization as of		418,782
Intangible asset, net of acumulated amorization as of		37,185
Balance of the intangible asset amortized		27,044
Common stock issued for patent			500,000
Legal fees Payable amount			47,595
Patent recorded an intangible asset			462,715
Shares issued per share value			$ 0.93
Assumed liability			47,595
Amount amortized for the period	12,758
Intangible asset, net of accumulated amortization value	$ 331,701